Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344052
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-03-27
Brief Title:
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Sponsor:
Stamford Pharmaceuticals Inc
Organization:
Stamford Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-27
First Submit QC Date:
April 2 2024
Study First Post Date:
2024-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL